Lung adenocarcinoma (LUAD) is a common type of lung cancer that arises from glandular cells in the lungs. Understanding the prognosis and classification of LUAD is crucial for determining ...

The following is a summary of “Biological characterization and clinical significance of cuproptosis-related genes in lung ...

Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to detect circulating tumour DNA can predict lung cancer outcome in a Cancer Research UK-funded study.

Adults with primary primary appendiceal adenocarcinoma face a higher risk of developing a second primary cancer, including ...

Squamous Cell Lung Carcinoma Symptoms Squamous cell lung carcinoma usually does not cause symptoms in the early stages. This means that it is often diagnosed in a later stage once symptoms begin.

Ultrasensitive ctDNA detection with NeXT Personal shows 81% sensitivity in early-stage lung adenocarcinoma, improving ...

Surufatinib plus TAS-102 showed promising survival benefits with manageable toxicity in refractory metastatic PDAC patients, ...

A DAILY pill that doubles survival time for lung cancer patients will be made routinely available on the NHS. Osimertinib, also known as Tagrisso and made by AstraZeneca, helps prevent cancer from ...

The unsuccessful Phase III results are the latest to suggest that the blockbuster cancer drug is finally bumping up against ...